top of page




Health Pitching Competition is for Finnish and Swiss early-stage science-based startups and pre-startups in the fields of healthtech, medtech,

digital health and pharma.

All finalists will

  • receive speaker coaching to prepare their pitch,

  • have the chance to present their idea on the Y Science stage,

  • meet potential investors,

  • network with experts in the fields of their solution

  • get a Slush ticket, and

  • a possibility to pitch their idea in a dedicated slot for the Y Science Health/Pharma Showcase during Slush at the Swisstech Pavilion


The winner will be granted 5,000 EUR to take their exciting idea further!


Competition timeline

  • September 1: Applications open

  • September 30: Applications close

  • October 13: Announcement of the finalists

  • October 24, 14:00 - 16:00 EEST: Introduction to pitching (online)

  • October 25 - November 23: 1-1 pitch coaching (online)

  • NEW: November 20, 13:30 - 15:00 EET: Public speaking workshop (Helsinki, Finland)

  • November 24, 12:00 - 13:00 EET: Final meeting for the pitching competition (online)

  • November 29, 15:30 - 18:30 EET: Dress rehearsal of the competition (Helsinki, Finland)

  • November 30: Health and Pharma pitching competition at Y Science

Jury for the selection of the 2023 finalists


  • Sanne Brun Jensen, Business Development Associate, BioInnovation Institute

  • Taylor Cooney, Science Strategy Associate, BioInnovation Institute

  • Alice Freton, Startup Program Manager, Innovation Office University of Basel

  • Franziska Steiner, Senior Opportunity Architect, Swiss Healthcare Startups / Swissnex

  • Marcel Hofstetter, Scientific Officer, Innosuisse

  • Ruth Sanz, Healthcare Innovation Implementation Manager, AstraZeneca

  • Parminder Bansal, Associate Director, Patient Experience and Innovation, AstraZeneca

  • Rauni Korolainen, Advisor, Health & Wellbeing, Invest in Finland, Business Finland

  • Alexandra Peth, Managing Director, Finnish Bioindustries FIB - Suomen Bioteollisuus ry

  • Matias Posa, Analyst, Innovestor

  • Cédric Odje, Investment Associate, Debiopharm

bottom of page